Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Current Leases: 2019-2024

Historic Current Leases for Agios Pharmaceuticals (AGIO) over the last 6 years, with Dec 2024 value amounting to $16.8 million.

  • Agios Pharmaceuticals' Current Leases rose 10.22% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 10.22%. This contributed to the annual value of $16.8 million for FY2024, which is 11.81% up from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Current Leases of $16.8 million as of FY2024, which was up 11.81% from $15.0 million recorded in FY2023.
  • Agios Pharmaceuticals' Current Leases' 5-year high stood at $16.8 million during FY2024, with a 5-year trough of $7.1 million in FY2020.
  • For the 3-year period, Agios Pharmaceuticals' Current Leases averaged around $15.2 million, with its median value being $15.0 million (2023).
  • Data for Agios Pharmaceuticals' Current Leases shows a peak YoY soared of 52.66% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Agios Pharmaceuticals' Current Leases stood at $7.1 million in 2020, then surged by 52.66% to $10.8 million in 2021, then climbed by 26.18% to $13.7 million in 2022, then climbed by 9.84% to $15.0 million in 2023, then grew by 11.81% to $16.8 million in 2024.